These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24051260)

  • 1. VAC protocol for treatment of dogs with stage III hemangiosarcoma.
    Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G
    J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with DAV for advanced-stage hemangiosarcoma in dogs.
    Dervisis NG; Dominguez PA; Newman RG; Cadile CD; Kitchell BE
    J Am Anim Hosp Assoc; 2011; 47(3):170-8. PubMed ID: 21498593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma.
    Hammer AS; Couto CG; Filppi J; Getzy D; Shank K
    J Vet Intern Med; 1991; 5(3):160-6. PubMed ID: 1920253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.
    Sorenmo KU; Jeglum KA; Helfand SC
    J Vet Intern Med; 1993; 7(6):370-6. PubMed ID: 8114034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
    Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
    Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
    Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ
    J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma.
    Finotello R; Stefanello D; Zini E; Marconato L
    Vet Comp Oncol; 2017 Mar; 15(1):25-35. PubMed ID: 25623994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
    Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
    J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
    Burton JH; Powers BE; Biller BJ
    Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014).
    Batschinski K; Nobre A; Vargas-Mendez E; Tedardi MV; Cirillo J; Cestari G; Ubukata R; Dagli MLZ
    Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
    Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
    Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
    Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
    Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.
    Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F
    J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
    Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
    J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
    U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
    J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
    Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
    Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
    Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.